Augmentation Cystoplasty Using an Autologous Neo-Bladder
| Status: | Terminated |
|---|---|
| Conditions: | Other Indications |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 3 - 21 |
| Updated: | 4/21/2016 |
| Start Date: | December 2006 |
| End Date: | April 2011 |
An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida
Subjects with neurogenic bladder secondary to spina bifida refractory to medical treatment
will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous
neo-bladder construct will significantly increase bladder compliance.
will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous
neo-bladder construct will significantly increase bladder compliance.
Subjects with neurogenic bladder secondary to spina bifida (myelodysplasia) that is
refractory to medical treatment and require augmentation cystoplasty will be enrolled. The
hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will
significantly increase bladder compliance.
refractory to medical treatment and require augmentation cystoplasty will be enrolled. The
hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will
significantly increase bladder compliance.
Inclusion Criteria:
- subjects with neurogenic bladders secondary to myleodysplasia
Exclusion Criteria:
- prior augment procedures
- recent urologic surgery
- requires concomitant urologic intervention
We found this trial at
1
site
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials
